Back to All

Diaceutics announces name change for company divisions

7 July, 2017

Diaceutics, the medtech company enabling better patient testing globally, announced today that its four divisions, Labceutics, Iceutics, Bioceutics and Analytics, Insights & Strategy (AIS), will re-align into one cohesive organization under the company name “Diaceutics.”

Newly appointed Managing Director of Marketing, Steve Vitale, said, “This change in branding has been made to reflect the growth of the Diaceutics service offering which leverages an expanding global network of laboratories to provide an end-to-end solution for our pharmaceutical clients. In essence, we are highlighting the foundation of the organization with this name change to align our corporate and divisional brand identities into one core vision. That vision which remains today, is to enable pharma to leverage diagnostic testing globally. Our team of global laboratory, diagnostic and pharmaceutical experts will remain unchanged. Working closely with our lab partners, Diaceutics will continue to lead the way in precision medicine by allowing our customers to integrate quality testing, drive more effective commercialization of targeted therapies and ensure that more patients can benefit from these potentially life-saving medications.”

From conception to the present day: read more about the evolution of Diaceutics since the company was founded in 2005 here: Corporate History

About Diaceutics

At Diaceutics we believe that every patient should get the precision medicine they deserve. We are a data analytics and end-to-end services provider enabled by DXRX - the world’s first Network solution for the development and commercialization of precision medicine diagnostics. 

Diaceutics has worked on every precision medicine brought to market and provides services to 36 of the world’s leading pharmaceutical companies. We have built the world’s largest repository of diagnostic testing data with a growing network of 2500 labs in 51 countries.